10-25% Off

Texas InstrumentsTLV73310PDQNTLinear Regulators

LDO Regulator Pos 1V 0.3A 4-Pin X2SON EP T/R

Never worry about components seeing unstable voltages again by implementing this LDO TLV73310PDQNT linear regulator manufactured by Texas Instruments. Its typical dropout voltage at current is 0.125@300mA V. It has an overall accuracy of ±1 %. This voltage regulation device's single output can produce a current up to 0.3 A. The best way to provide power to your application is by using this, which needs a voltage of at least 1.4 V and no higher than 5.5 V. With an adjustable output that has a voltage of 1 to 3.3 V, this is power management at its best. To produce a constant current at your output, supply your circuit with a load regulation of 16mV(Typ) and line regulation of 1mV/V(Typ). Tape and reel packaging will encase this product during shipment, in order to ensure safe delivery and enable quick mounting of components. This voltage regulation device has an operating temperature range of -40 °C to 125 °C. The maximum dropout voltage is 0.42@300mA|0.37@300mA|0.27@300mA|0.26@300mA|0.45@300mA|0.4@300mA|0.3@300mA|0.29@300mA|0.27@300mA V. Its polarity is positive.

Import TariffMay apply to this part

49 parts: Ships tomorrow

    Total$0.15Price for 1

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      1644+
      Manufacturer Lead Time:
      12 weeks
      Minimum Of :
      1
      Maximum Of:
      49
      Country Of origin:
      China
         
      • Price: $0.1458
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      1644+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      China
      • In Stock: 49 parts
      • Price: $0.1458

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.